Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 13355
Country/Region: Tanzania
Year: 2015
Main Partner: Ministry of Health and Social Welfare - Tanzania
Main Partner Program: Zanzibar AIDS Control Program
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Strategic Information (HVSI) $0
Biomedical Prevention: Blood Safety (HMBL) $0
Testing: HIV Testing and Counseling (HVCT) $0
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 5,185
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 2,188
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 8,685
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 184
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 174
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 119
PMTCT_ARV Sum of New and Current disaggregates 2016 174
PMTCT_CTX Number of infants born to HIV-infected women who were started on cotrimoxizole (CTX) prophylaxis within 2 months of birth within the reporting period 2016 147
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 120
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 51
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 171
PMTCT_EID Sum of Infant Age disaggregates 2016 171
PMTCT_STAT By: Known positives at entry 2016 55
PMTCT_STAT By: Number of new positives identified 2016 129
PMTCT_STAT Number of new ANC and L&D clients 2016 22,271
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 21,161
PMTCT_STAT Sum of Positives Status disaggregates 2016 184
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 5,185
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 4,726
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 2,084